TGF-β-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-β type I receptor fusion proteins

Chemistry and Biology

Volumn 5, Issue 7, 1998, Pages 385-395

  Stockwell, Brent R ^a   Schreiber, Stuart L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

FK506; FKBP; Rapamycin; Smad; TGF

Indexed keywords

CELL GROWTH; GLYCINE; GREEN FLUORESCENT PROTEIN; GROWTH DISORDER; HYBRID PROTEIN; IMMUNOPHILIN; MUTATION; MYRISTYLATION; PLASMID; PLASMINOGEN ACTIVATOR INHIBITOR 1; RAPAMYCIN; SERINE; TRANSFORMING GROWTH FACTOR BETA;

MUSTELA VISON;

EID: 0031874150     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(98)90072-2     Document Type: Article

References (42)

1. Daopin, S., Piez, K.A., Ogawa, Y. & Davies, D.R. (1992). Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science 257, 369-373.
2. Schlunegger, M.P. & Grutter, M.G. (1992). An unusual feature revealed by the crystal structure at 2.2 Å resolution of human transforming growth factor-β2. Nature 358, 430-434.
3. Isaacs, N.W. (1995). Cystine knots. Curr. Opin. Struct. Biol. 5, 391-395.
4. Roberts, A.B. & Sporn, M.B. (1990). In Peptide Growth Factors and Their Receptors (Sporn, M.B. & Roberts, A.B., eds) pp. 419-472, Springer-Verlag, Heidelberg.
5. Massague, J. & Weis-Garcia, F. (1996). Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv. 27, 41-64.
6. Attisano, L. & Wrana, J.L. (1996). Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev. 7, 327-339.
7. Yamashita, H., ten Dijke, P., Franzen, P., Miyazono, K. & Heldin, C.-H. (1994). Formation of hetero-oligomeric complexes of type I and type Il receptors for transforming growth factor-β. J. Biol. Chem. 269, 20172-20178.
8. Thomsen, G.H. (1996). Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. Development 122, 2359-2366.
9. Graff, J.M., Bansal, A. & Melton, D.A. (1996). Xenopus mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85, 479-487.
10. Baker, J.C. & Harland, R.M. (1996). A novel mesoderm inducer, MADR2, functions in the activin signal transduction pathway. Genes Dev. 10, 1880-1889.
11. Zhang, Y., Feng, X.-H., Wu, R.-Y. & Derynck, R. (1996). Receptor-associated mad homologues synergize as effectors of the TGF-β response. Nature 383, 168-172.
12. Lagna, G., Hata, A., Hemmati-Brivanlou, A. & Massague, J. (1996). Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways. Nature 383, 832-836.
13. Topper, J.N., et al., & Falb, D. (1997). Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl Acad. Sci. USA 94, 9314-9319.
14. Imamura, T., et al., & Miyazono, K. (1997). Smad6 inhibits signaling by the TGF-β superfamily. Nature 389, 622-626.
15. Nakao, A., et al., & ten Dijke, P. (1997). Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signaling. Nature 389, 631-635.
16. Liu, X., Sun, Y., Constantinescu, S.N., Karam, E., Weinberg, R.A. & Lodish, H.F. (1997). Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl Acad. Sci. USA 94, 10669-10674.
17. Macias-Silva, M., Abdollah, S., Hoodless, P.A., Pirone, R., Attisano, L. & Wrana, J.L. (1996). MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215-1224.
18. Nakao, A., et al., & ten Dijke, P. (1997). TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362.
19. 467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272, 27678-27685.
20. Chen, X., Rubock, M.J. & Whitman, M. (1996). A transcriptional partner for MAD proteins in TGF-β signaling. Nature 383, 691-696.
21. Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., Naco, G. & Whitman, M. (1997). Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389, 85-89.
22. Kim, J., Johnson, K., Chen, H,J., Carroll, S. & Laughon, A. (1997). Drosophila mad binds to DNA and directly mediates activation of vestigial by decapentaplegic. Nature 388, 304-308.
23. RAS farnesyltransferase α subunit in TGF-β and activin signaling. Science 271, 1120-1122.
24. Ventura, F., Liu, F., Doody, J, & Massague, J. (1996). Interaction of transforming growth factor-β receptor I with farnesyl-protein transferase-α in yeast and mammalian cells. J. Biol. Chem. 271, 13931-13934.
25. Kawabata, M., Imamura, T., Miyazono, K., Engel, M.E. & Moses, H.L. (1995). Interaction of the transforming growth factor-β type I receptor with farnesyl-protein transferase-α. J. Biol. Chem. 270, 29628-29631.
26. Wang, T., Donahoe, P.K. & Zervos, A.S. (1994). Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP12. Science 265, 674-676.
27. Chen, R.-H., Miettinen, P.J., Maruoka, E.M., Choy, L. & Derynck, R. (1995). A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature 377, 548-552.
28. Wang, T., et al., & Donohoe, P.K. (1996). The immunophilin FKBP12 functions as a common inhibitor of the TGF-β family type I receptors. Cell 86, 1-20.
29. Okadome, T., et al., & Kawabata, M. (1996). Characterization of the interaction of FKBP12 with the transforming growth factor-β type I receptor in vivo. J. Biol. Chem. 271, 21687-21690.
30. Charng, M.-J., Kinnunen, P., Hawkers, J., Brand, T. & Schneider, M.D. (1996). FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-β receptors. J. Biol. Chem. 271, 22941-22944.
31. Chen, Y.-G., Liu, F. & Massague, J. (1997). Mechanism of TGF-β receptor inhibition by FKBP12. EMBO J. 16, 3866-3876.
32. Wrana, J.L., et al., & Massague, J. (1992). TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
33. Stockwell, B.R. & Schreiber, S.L. (1998). Probing the role of homomeric and heteromeric receptor interactions in TGF-β signaling using small molecule dimerizers. Curr. Biol. 8, 761-770.
34. Spencer, D.M., Wandless, T.J., Schreiber, S.L. & Crabtree, G.R. (1993). Controlling signal transduction with synthetic ligands. Science 262, 1019-1024.
35. Yang, D., Rosen, M.K. & Schreiber, S.L. (1993). A composite FKBP12-FK506 surface that contacts calcineurin. J. Am. Chem. Soc. 115, 819-820.
36. Wieser, R., Wrana, J.L. & Massague, J. (1995). GS domain mutations that constitutively activate TβRI, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14, 2199-2208.
37. Laiho, M., Weis, F.M.B. & Massague, J. (1990). Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265, 18518-18524.
38. Feng, X.-H., Filvaroff, E.H. & Derynck, R. (1995). Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J. Biol. Chem. 270, 24237-24245.
39. Belshaw, P.J., Ho, S.N., Crabtree, G.R. & Schreiber, S.L. (1996). Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc. Natl Acad. Sci. USA 93, 4604-4607.
40. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F. & Massague, J. (1994). Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
41. Shou, W., et al., & Matzuk, M.M. (1998). Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature 391, 489-492.
42. Bassing, C.H., et al., & Wang, X.-F. (1994). A transforming growth factor β type I receptor that signals to activate gene expression. Science 263, 87-89.